February 5, 2010 — Results from 8 clinical trials show that recombinant human thrombin (rThrombin; Recothrom, ZymoGenetics, Inc) is well tolerated in several surgical settings for topical hemostasis ...
Thrombosis, the clogging of blood vessels, is a major cause of heart attacks and embolism. Scientists have now engineered the first inhibitors of thrombin, a protease promoting thrombosis, that is ...
If you get a blood clot in your leg or another large blood vessel called a deep vein thrombosis (DVT), your treatment will include medications known as blood thinners. These drugs, also called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback